Hepatitis B reactivation during ruxolitinib treatment

Ann Hematol. 2022 Sep;101(9):2081-2086. doi: 10.1007/s00277-022-04851-6. Epub 2022 Apr 30.

¹ Emergency Service, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
² Service of Clinical Pharmacology, Department of Laboratory Medicine and Pathology, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
³ Division of Gastroenterology and Hepatology, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland.
⁴ Service and Central Laboratory of Hematology, Department of Oncology and Department of Laboratory Medicine and Pathology, Lausanne University Hospital (CHUV), University of Lausanne (UNIL), Rue du Bugnon 46, CH-1011, Lausanne, Switzerland.
⁵ Service and Central Laboratory of Hematology, Department of Oncology and Department of Laboratory Medicine and Pathology, Lausanne University Hospital (CHUV), University of Lausanne (UNIL), Rue du Bugnon 46, CH-1011, Lausanne, Switzerland. sabine.blum@chuv.ch.

No abstract available

Publication types